Drug Trial Radar · NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
May 23, 2028
Study completion May 23, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).
Conditions
- Type 2 Diabetes Mellitus
Interventions
ElecoglipronDrug
Elecoglipron is administered orally once daily.
SemaglutideDrug
Semaglutide is administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline to Week 52
Locations
210 sites in 15 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Not yet recruiting
Research Site
Mesa, Arizona · Not yet recruiting
Research Site
Phoenix, Arizona · Recruiting
Research Site
Tempe, Arizona · Not yet recruiting
Research Site
Covina, California · Not yet recruiting
Research Site
Encinitas, California · Recruiting
Research Site
Garden Grove, California · Not yet recruiting
Research Site
Loma Linda, California · Not yet recruiting
Research Site
Long Beach, California · Not yet recruiting
Research Site
Pomona, California · Recruiting
Research Site
Sacramento, California · Recruiting
Research Site
Bridgeport, Connecticut · Not yet recruiting
Research Site
Crystal River, Florida · Not yet recruiting
Research Site
Hollywood, Florida · Not yet recruiting
Research Site
Jacksonville, Florida · Not yet recruiting
Research Site
Lake City, Florida · Recruiting
Research Site
Leesburg, Florida · Recruiting
Research Site
Orlando, Florida · Not yet recruiting
Research Site
Lilburn, Georgia · Not yet recruiting
Research Site
Idaho Falls, Idaho · Not yet recruiting
Research Site
Melrose Park, Illinois · Not yet recruiting
Research Site
Evansville, Indiana · Not yet recruiting
Research Site
Ames, Iowa · Recruiting
Research Site
Wichita, Kansas · Not yet recruiting
Research Site
Bowling Green, Kentucky · Not yet recruiting
Research Site
Rockville, Maryland · Not yet recruiting
Research Site
Rockville, Maryland · Recruiting
Research Site
Southfield, Michigan · Not yet recruiting
Research Site
Minneapolis, Minnesota · Not yet recruiting
Research Site
Jefferson City, Missouri · Not yet recruiting
Research Site
Kansas City, Missouri · Not yet recruiting
Research Site
Omaha, Nebraska · Not yet recruiting
Research Site
Henderson, Nevada · Recruiting
Research Site
Las Vegas, Nevada · Not yet recruiting
Research Site
Albuquerque, New Mexico · Not yet recruiting
Research Site
Durham, North Carolina · Not yet recruiting
Research Site
Morehead City, North Carolina · Recruiting
Research Site
Raleigh, North Carolina · Not yet recruiting
Research Site
Statesville, North Carolina · Not yet recruiting
Research Site
Wilmington, North Carolina · Recruiting
Showing 40 of 210 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.